Literature DB >> 21691558

Elevated pancreatic enzymes, IgM, soluble interleukin-2 receptor in anti-GADab(+) type 1 diabetes.

Hidekatsu Yanai1, Sumie Moriyama.   

Abstract

Type 1 diabetes can be classified into immune-mediated diabetes (type 1A) and idiopathic diabetes, which lacks immunological evidence for beta cell autoimmunity (type 1B). Type 1A diabetes is characterized by the presence of the anti-glutamic acid decarboxylase antibody (anti-GADab). Fulminant type 1 diabetes is classified as type 1B diabetes, and characterized by the absence of anti-GADab, flu-like symptoms, and elevated serum exocrine pancreatic enzymes. We report a type 1 diabetic patient who showed flu-like symptoms, elevated serum exocrine pancreatic enzymes, and an extremely high-titer of anti-GADab, manifesting the characteristics of both type 1A and fulminant type 1 diabetes.

Entities:  

Keywords:  Anti-glutamic acid decarboxylase antibody; Exocrine pancreatic enzymes; Soluble interleukin-2 receptor; Type 1 diabetes

Year:  2011        PMID: 21691558      PMCID: PMC3116011          DOI: 10.4239/wjd.v2.i5.75

Source DB:  PubMed          Journal:  World J Diabetes        ISSN: 1948-9358


  9 in total

1.  Pathogenesis of fulminant type 1 diabetes.

Authors:  Akihisa Imagawa; Toshiaki Hanafusa
Journal:  Rev Diabet Stud       Date:  2007-02-10

Review 2.  Fulminant type 1 diabetes: a novel clinical entity requiring special attention by all medical practitioners.

Authors:  Toshiaki Hanafusa; Akihisa Imagawa
Journal:  Nat Clin Pract Endocrinol Metab       Date:  2007-01

3.  Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus.

Authors: 
Journal:  Diabetes Care       Date:  1997-07       Impact factor: 19.112

4.  Fulminating onset type 1 diabetes with positivity for anti-GAD antibody and elevated pancreatic exocrine enzyme concentrations.

Authors:  Toshio Kahara; Toshinari Takamura; Hitoshi Ando; Masaru Sakurai; Tsuguhito Ota; Tsuguho Misaki; Sakae Oba; Masaharu Iguchi; Kazutoshi Komori; Ken-ichi Kobayashi
Journal:  Intern Med       Date:  2003-06       Impact factor: 1.271

5.  Fulminant type 1 diabetes: a nationwide survey in Japan.

Authors:  Akihisa Imagawa; Toshiaki Hanafusa; Yasuko Uchigata; Azuma Kanatsuka; Eiji Kawasaki; Tetsuro Kobayashi; Akira Shimada; Ikki Shimizu; Tetsuya Toyoda; Taro Maruyama; Hideichi Makino
Journal:  Diabetes Care       Date:  2003-08       Impact factor: 19.112

6.  Insulitis in human type 1 diabetes.

Authors:  Toshiaki Hanafusa; Akihisa Imagawa
Journal:  Ann N Y Acad Sci       Date:  2008-12       Impact factor: 5.691

7.  A case of abrupt onset autoimmune type 1 diabetes mimicking fulminant type 1 diabetes.

Authors:  Shinya Makino; Sumio Hamada; Masanobu Iwata; Masayoshi Fujiwara
Journal:  Endocr J       Date:  2009-08-13       Impact factor: 2.349

8.  A case of fulminant type 1 diabetes with transiently positive anti-GAD antibodies.

Authors:  Taisuke Iwaoka
Journal:  Endocr J       Date:  2003-04       Impact factor: 2.349

9.  Diagnosis and classification of diabetes mellitus.

Authors: 
Journal:  Diabetes Care       Date:  2011-01       Impact factor: 19.112

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.